Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injections

Saved in:
Bibliographic Details
Main Authors: Miguel Figallo, María F. Delgado, Mauricio Gonzalez, Adrián Arenas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554192/?tool=EBI
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849221361263706112
author Miguel Figallo
María F. Delgado
Mauricio Gonzalez
Adrián Arenas
author_facet Miguel Figallo
María F. Delgado
Mauricio Gonzalez
Adrián Arenas
author_sort Miguel Figallo
collection DOAJ
format Article
id doaj-art-c62fca8dc30246bea47ce848795c49a5
institution Kabale University
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-c62fca8dc30246bea47ce848795c49a52024-11-15T05:31:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011911Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injectionsMiguel FigalloMaría F. DelgadoMauricio GonzalezAdrián Arenashttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554192/?tool=EBI
spellingShingle Miguel Figallo
María F. Delgado
Mauricio Gonzalez
Adrián Arenas
Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injections
PLoS ONE
title Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injections
title_full Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injections
title_fullStr Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injections
title_full_unstemmed Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injections
title_short Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injections
title_sort cost minimization analysis of treatments for metastatic her2 positive breast cancer in peru fixed dose combination of pertuzumab and trastuzumab for subcutaneous injections
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554192/?tool=EBI
work_keys_str_mv AT miguelfigallo costminimizationanalysisoftreatmentsformetastaticher2positivebreastcancerinperufixeddosecombinationofpertuzumabandtrastuzumabforsubcutaneousinjections
AT mariafdelgado costminimizationanalysisoftreatmentsformetastaticher2positivebreastcancerinperufixeddosecombinationofpertuzumabandtrastuzumabforsubcutaneousinjections
AT mauriciogonzalez costminimizationanalysisoftreatmentsformetastaticher2positivebreastcancerinperufixeddosecombinationofpertuzumabandtrastuzumabforsubcutaneousinjections
AT adrianarenas costminimizationanalysisoftreatmentsformetastaticher2positivebreastcancerinperufixeddosecombinationofpertuzumabandtrastuzumabforsubcutaneousinjections